vs
Side-by-side financial comparison of Brighthouse Financial, Inc. (BHF) and Zoetis (ZTS). Click either name above to swap in a different company.
Zoetis is the larger business by last-quarter revenue ($2.3B vs $1.7B, roughly 1.3× Brighthouse Financial, Inc.). Zoetis runs the higher net margin — 26.6% vs 8.1%, a 18.5% gap on every dollar of revenue. On growth, Brighthouse Financial, Inc. posted the faster year-over-year revenue change (40.2% vs 2.9%). Over the past eight quarters, Brighthouse Financial, Inc.'s revenue compounded faster (9.8% CAGR vs -2.1%).
Brighthouse Financial, Inc. is an American insurance company, headquartered in Charlotte, North Carolina, that sells annuity and life insurance. As of March 2018, Brighthouse was one of the largest providers of annuities and life insurance in the United States, with $219 billion in total assets and around 2.6 million insurance policies and annuity contracts in-force . During the same year Brighthouse Financial along with 90 additional Fortune 500 companies "paid an effective federal tax rate ...
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
BHF vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $2.3B |
| Net Profit | $137.0M | $601.0M |
| Gross Margin | — | 71.7% |
| Operating Margin | 8.9% | — |
| Net Margin | 8.1% | 26.6% |
| Revenue YoY | 40.2% | 2.9% |
| Net Profit YoY | -79.6% | -0.2% |
| EPS (diluted) | $1.84 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.3B | ||
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | $1.8B | $2.4B | ||
| Q2 25 | $871.0M | $2.5B | ||
| Q1 25 | $2.4B | $2.2B | ||
| Q4 24 | $1.2B | $2.3B | ||
| Q3 24 | $2.0B | $2.4B | ||
| Q2 24 | $1.4B | $2.4B |
| Q1 26 | — | $601.0M | ||
| Q4 25 | $137.0M | $603.0M | ||
| Q3 25 | $479.0M | $721.0M | ||
| Q2 25 | $85.0M | $718.0M | ||
| Q1 25 | $-268.0M | $631.0M | ||
| Q4 24 | $671.0M | $581.0M | ||
| Q3 24 | $176.0M | $682.0M | ||
| Q2 24 | $34.0M | $624.0M |
| Q1 26 | — | 71.7% | ||
| Q4 25 | — | 70.2% | ||
| Q3 25 | — | 71.5% | ||
| Q2 25 | — | 73.6% | ||
| Q1 25 | — | 72.0% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 71.7% |
| Q1 26 | — | — | ||
| Q4 25 | 8.9% | 31.9% | ||
| Q3 25 | 32.2% | 37.0% | ||
| Q2 25 | 10.7% | 36.7% | ||
| Q1 25 | -14.8% | 36.5% | ||
| Q4 24 | 69.2% | 31.6% | ||
| Q3 24 | 9.3% | 36.6% | ||
| Q2 24 | 1.0% | 33.0% |
| Q1 26 | — | 26.6% | ||
| Q4 25 | 8.1% | 25.3% | ||
| Q3 25 | 26.4% | 30.0% | ||
| Q2 25 | 9.8% | 29.2% | ||
| Q1 25 | -11.2% | 28.4% | ||
| Q4 24 | 55.7% | 25.1% | ||
| Q3 24 | 8.7% | 28.6% | ||
| Q2 24 | 2.4% | 26.4% |
| Q1 26 | — | $1.42 | ||
| Q4 25 | $1.84 | $1.37 | ||
| Q3 25 | $7.89 | $1.63 | ||
| Q2 25 | $1.02 | $1.61 | ||
| Q1 25 | $-5.04 | $1.41 | ||
| Q4 24 | $10.27 | $1.29 | ||
| Q3 24 | $2.47 | $1.50 | ||
| Q2 24 | $0.12 | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $6.8B | — |
| Total Assets | $241.8B | — |
| Debt / EquityLower = less leverage | 0.47× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | $1.9B | $2.0B | ||
| Q3 24 | $1.8B | $1.7B | ||
| Q2 24 | $1.4B | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
| Q1 26 | — | — | ||
| Q4 25 | $6.8B | $3.3B | ||
| Q3 25 | $6.4B | $5.4B | ||
| Q2 25 | $5.7B | $5.0B | ||
| Q1 25 | $5.2B | $4.7B | ||
| Q4 24 | $5.0B | $4.8B | ||
| Q3 24 | $5.5B | $5.2B | ||
| Q2 24 | $4.1B | $5.0B |
| Q1 26 | — | — | ||
| Q4 25 | $241.8B | $15.5B | ||
| Q3 25 | $244.7B | $15.2B | ||
| Q2 25 | $242.6B | $14.5B | ||
| Q1 25 | $234.7B | $14.1B | ||
| Q4 24 | $238.5B | $14.2B | ||
| Q3 24 | $245.2B | $14.4B | ||
| Q2 24 | $237.4B | $14.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.47× | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | 0.56× | — | ||
| Q1 25 | 0.60× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-3.0M | $893.0M | ||
| Q3 25 | $117.0M | $938.0M | ||
| Q2 25 | $-1.0M | $486.0M | ||
| Q1 25 | $146.0M | $587.0M | ||
| Q4 24 | $-118.0M | $905.0M | ||
| Q3 24 | $24.0M | $951.0M | ||
| Q2 24 | $334.0M | $502.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $732.0M | ||
| Q3 25 | — | $805.0M | ||
| Q2 25 | — | $308.0M | ||
| Q1 25 | — | $438.0M | ||
| Q4 24 | — | $689.0M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $370.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.7% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 12.5% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | — | 32.8% | ||
| Q2 24 | — | 15.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 5.6% |
| Q1 26 | — | — | ||
| Q4 25 | -0.02× | 1.48× | ||
| Q3 25 | 0.24× | 1.30× | ||
| Q2 25 | -0.01× | 0.68× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | -0.18× | 1.56× | ||
| Q3 24 | 0.14× | 1.39× | ||
| Q2 24 | 9.82× | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHF
| Annuities | $926.0M | 55% |
| Runoff | $319.0M | 19% |
| Life | $298.0M | 18% |
| Other | $78.0M | 5% |
| Distribution Service | $66.0M | 4% |
| Accident And Health Insurance Segment | $2.0M | 0% |
ZTS
| Companion Animal | $1.5B | 67% |
| Livestock | $720.0M | 32% |
| Contract Manufacturing & Human Health | $23.0M | 1% |
